Independent oncogenic and therapeutic significance of phosphatase PRL‐3 in FLT3‐ITD–negative acute myeloid leukemia

E-ISSN： 1097-0142|120|14|2130-2141

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.14, 2014-07, pp. : 2130-2141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1065-1070

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is allogeneic transplantation really the best treatment for FLT3/ITD‐positive acute myeloid leukemia? A systematic review

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 2, 2015-02 ,pp. : 149-160

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 6, 2015-06 ,pp. : 1048-1054

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Surface Molecular Signature of Leukemic Cells Is Associated with NPM1 Mutations and FLT3-ITD in Patients with de novo Acute Myeloid Leukemia

Acta Haematologica, Vol. 131, Iss. 3, 2013-10 ,pp. : 148-152

Karger

Access to resources Recommend Favorite

Implications of FLT3 Mutations in the Therapy of Acute Myeloid Leukemia

Reviews on Recent Clinical Trials, Vol. 2, Iss. 2, 2007-05 ,pp. : 135-141

Bentham Science Publishers

Access to resources Recommend Favorite